Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
1 clinical trials · Condition
◉ Watch Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
| Record | Firm | Date |
|---|---|---|
| Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02272790) | AstraZeneca | 2015-01-30 |
Track Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.